aposuprid 200 mg tabletki
aurovitas pharma polska sp. z o.o. - amisulpridum - tabletki - 200 mg
aposuprid 400 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - amisulpridum - tabletki powlekane - 400 mg
apodream 7,5 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - zopiclonum - tabletki powlekane - 7,5 mg
sarclisa
sanofi winthrop industrie - isatuximab - szpiczak mnogi - Środki przeciwnowotworowe - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.
xonvea 10 mg + 10 mg tabletki dojelitowe
exeltis poland sp. z o.o. - doxylamini hydrogenosuccinas + pyridoxini hydrochloridum - tabletki dojelitowe - 10 mg + 10 mg